DAY 1 – Friday, 21 October 2016
Opening Video
Welcome and Introduction to EndoBridge 2016
Recent advances in clinical and molecular understanding of metabolic bone disease
– Nilgün Güvener Demirað
Approach to “drug holidays” "treatment failures" and possible combination therapy for postmenopausal osteoporosis
– Hasan Aydýn
Medical therapy in primary hyperparathyroidism
– Peter Schwarz
DAY 2 – Saturday, 22 October 2016
What is new in insulin therapy of diabetes?
–
Richard Holt
Bariatric - metabolic surgery in type 2 diabetes
–
Kåre Birkeland
Care of transgender
patients
–
Joshua Safer
DAY 3 – Sunday, 23 October 2016
Evaluation and management of sellar masses
– Vera Popovic
Can we really cure Cushing’s disease?
–
Susan Webb
Medically refractory prolactinoma
–
John Wass
Challenges and controversies in diagnosis and management of acromegaly
–
Pýnar Kadýoðlu
Ectopic fat: A new target for CVD risk management
–
Marja - Riitta Taskinen supported by ICCR
Food addiction: Does it really exist?
–
AJ Van der Lely
Closing comments and adjourn
